阿片依赖者的长期替代治疗(维持治疗)。

GMS health technology assessment Pub Date : 2007-03-27
Martin Busch, Sabine Haas, Marion Weigl, Charlotte Wirl
{"title":"阿片依赖者的长期替代治疗(维持治疗)。","authors":"Martin Busch,&nbsp;Sabine Haas,&nbsp;Marion Weigl,&nbsp;Charlotte Wirl","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Health political background: </strong>Methadone substitution treatment in Germany is introduced in 1988 in the framework of a scientific pilot study in North Rhein Westphalia. Recent statistics show that by now a broad offer of substitution treatment exists. From 1 June 2002 to 31 December 2003 113,000 substitution treatments have been recorded as being started of which around 56,000 have been recorded as ongoing treatments by 1 December 2003.</p><p><strong>Scientific background: </strong>Substitution treatment (treatment of opioid-dependent persons using substitution substances) is one part of addiction treatment. Its goals are harm reduction and the stabilisation of opioid dependent persons. Integration of opioid-dependent persons in a treatment-setting, reduction of consumption of psychoactive substances, reduction of risk behaviour (primarily related to infectious diseases), decrease of mortality and improvements concerning the social, psychic and physic situation are seen as a success of substitution treatment as maintenance therapy.</p><p><strong>Research questions: </strong>The aim of this HTA report is to investigate which indicators can be used to evaluate the effectiveness of substitution treatment. Based on these indicators an evaluation of the medical, social and economical benefit of substitution treatment - also in relation to abstinence oriented treatment - is carried out.</p><p><strong>Methods: </strong>A systematic literature search was performed in 31 international databases which yielded 2451 articles with publication date between 1995 and February 2005.</p><p><strong>Results: </strong>After a twofold selection process 32 publications were included for assessment and 276 publications were used as background literature. Despite serious restrictions due to selection bias and dropout in most studies focusing on substitution treatment, reduction of consumption of illegal opioids, reduction of risk behaviour, criminal behaviour, mortality and incidence of HIV can be seen as an empirically proven success of substitution treatment. Concerning the improvement of life and health situation the results of the studies are contradictory. The results show that retention rate of substitution treatment is higher than retention rate of abstinence oriented treatment. Regarding economical aspects substitution treatment is efficient in avoiding secondary illnesses (infections) and decreasing criminality. From the perspective of medical ethics substitution treatment as well as medical prescription of heroin is in principle acceptable.</p><p><strong>Discussion and conclusions: </strong>Based on these results, it can be recommended that substitution treatment in principle should be made available for all opioid dependent persons. The decision whether substitution treatment or another treatment (e. g. abstinence oriented treatment) is more promising has to take into account the individual situation of the client. In addition a combination of substitution treatment and abstinence oriented treatment might be promising although there is a lack of studies about this approach. In any case the decision concerning a certain form of treatment should leave aside pseudo-moralic concerns and should be made on the base of established medical ethic principles - like the interest of the patient - taking into account the specific situation of the client.</p>","PeriodicalId":89142,"journal":{"name":"GMS health technology assessment","volume":"3 ","pages":"Doc04"},"PeriodicalIF":0.0000,"publicationDate":"2007-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/14/HTA-03-04.PMC3011334.pdf","citationCount":"0","resultStr":"{\"title\":\"Long term substitution treatment (maintenance treatment) of opioid dependent persons.\",\"authors\":\"Martin Busch,&nbsp;Sabine Haas,&nbsp;Marion Weigl,&nbsp;Charlotte Wirl\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Health political background: </strong>Methadone substitution treatment in Germany is introduced in 1988 in the framework of a scientific pilot study in North Rhein Westphalia. Recent statistics show that by now a broad offer of substitution treatment exists. From 1 June 2002 to 31 December 2003 113,000 substitution treatments have been recorded as being started of which around 56,000 have been recorded as ongoing treatments by 1 December 2003.</p><p><strong>Scientific background: </strong>Substitution treatment (treatment of opioid-dependent persons using substitution substances) is one part of addiction treatment. Its goals are harm reduction and the stabilisation of opioid dependent persons. Integration of opioid-dependent persons in a treatment-setting, reduction of consumption of psychoactive substances, reduction of risk behaviour (primarily related to infectious diseases), decrease of mortality and improvements concerning the social, psychic and physic situation are seen as a success of substitution treatment as maintenance therapy.</p><p><strong>Research questions: </strong>The aim of this HTA report is to investigate which indicators can be used to evaluate the effectiveness of substitution treatment. Based on these indicators an evaluation of the medical, social and economical benefit of substitution treatment - also in relation to abstinence oriented treatment - is carried out.</p><p><strong>Methods: </strong>A systematic literature search was performed in 31 international databases which yielded 2451 articles with publication date between 1995 and February 2005.</p><p><strong>Results: </strong>After a twofold selection process 32 publications were included for assessment and 276 publications were used as background literature. Despite serious restrictions due to selection bias and dropout in most studies focusing on substitution treatment, reduction of consumption of illegal opioids, reduction of risk behaviour, criminal behaviour, mortality and incidence of HIV can be seen as an empirically proven success of substitution treatment. Concerning the improvement of life and health situation the results of the studies are contradictory. The results show that retention rate of substitution treatment is higher than retention rate of abstinence oriented treatment. Regarding economical aspects substitution treatment is efficient in avoiding secondary illnesses (infections) and decreasing criminality. From the perspective of medical ethics substitution treatment as well as medical prescription of heroin is in principle acceptable.</p><p><strong>Discussion and conclusions: </strong>Based on these results, it can be recommended that substitution treatment in principle should be made available for all opioid dependent persons. The decision whether substitution treatment or another treatment (e. g. abstinence oriented treatment) is more promising has to take into account the individual situation of the client. In addition a combination of substitution treatment and abstinence oriented treatment might be promising although there is a lack of studies about this approach. In any case the decision concerning a certain form of treatment should leave aside pseudo-moralic concerns and should be made on the base of established medical ethic principles - like the interest of the patient - taking into account the specific situation of the client.</p>\",\"PeriodicalId\":89142,\"journal\":{\"name\":\"GMS health technology assessment\",\"volume\":\"3 \",\"pages\":\"Doc04\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/14/HTA-03-04.PMC3011334.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"GMS health technology assessment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS health technology assessment","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

健康政治背景:1988年,在北莱茵-威斯特伐利亚州的一项科学试点研究框架内,德国引入了美沙酮替代治疗。最近的统计数据显示,目前存在广泛的替代治疗。从2002年6月1日至2003年12月31日,已有113 000项替代治疗被记录为已开始,其中约56 000项被记录为截至2003年12月1日正在进行的治疗。科学背景:替代治疗(使用替代物质治疗阿片类药物依赖者)是成瘾治疗的一部分。其目标是减少危害和稳定阿片类药物依赖者。将阿片类药物依赖者纳入治疗环境,减少精神活性物质的消费,减少危险行为(主要与传染病有关),降低死亡率,改善社会、心理和身体状况,这些都被视为替代治疗作为维持治疗的成功。研究问题:本HTA报告的目的是调查哪些指标可用于评估替代治疗的有效性。在这些指标的基础上,对替代治疗的医疗、社会和经济效益进行了评估,也对以禁欲为导向的治疗进行了评估。方法:系统检索国际31个数据库,共收录1995 ~ 2005年2月发表的文献2451篇。结果:经过两次筛选,共纳入32篇文献进行评估,276篇文献作为背景文献。尽管在大多数侧重于替代治疗的研究中由于选择偏差和辍学而受到严重限制,但减少非法阿片类药物的消费、减少危险行为、犯罪行为、死亡率和艾滋病毒发病率可被视为经验证明的替代治疗的成功。关于生活和健康状况的改善,研究结果是矛盾的。结果表明,替代治疗的保留率高于戒断治疗的保留率。在经济方面,替代治疗在避免继发性疾病(感染)和减少犯罪方面是有效的。从医学伦理学的角度看,海洛因的替代治疗和医疗处方在原则上是可以接受的。讨论和结论:基于这些结果,可以建议原则上应该为所有阿片类药物依赖者提供替代治疗。决定替代治疗或另一种治疗(例如以戒断为导向的治疗)更有希望,必须考虑到客户的个人情况。此外,替代治疗和禁欲导向治疗的结合可能是有希望的,尽管缺乏关于这种方法的研究。在任何情况下,关于某种形式的治疗的决定都应抛开伪道德问题,并应根据既定的医学伦理原则——比如病人的利益——考虑到病人的具体情况作出决定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Long term substitution treatment (maintenance treatment) of opioid dependent persons.

Health political background: Methadone substitution treatment in Germany is introduced in 1988 in the framework of a scientific pilot study in North Rhein Westphalia. Recent statistics show that by now a broad offer of substitution treatment exists. From 1 June 2002 to 31 December 2003 113,000 substitution treatments have been recorded as being started of which around 56,000 have been recorded as ongoing treatments by 1 December 2003.

Scientific background: Substitution treatment (treatment of opioid-dependent persons using substitution substances) is one part of addiction treatment. Its goals are harm reduction and the stabilisation of opioid dependent persons. Integration of opioid-dependent persons in a treatment-setting, reduction of consumption of psychoactive substances, reduction of risk behaviour (primarily related to infectious diseases), decrease of mortality and improvements concerning the social, psychic and physic situation are seen as a success of substitution treatment as maintenance therapy.

Research questions: The aim of this HTA report is to investigate which indicators can be used to evaluate the effectiveness of substitution treatment. Based on these indicators an evaluation of the medical, social and economical benefit of substitution treatment - also in relation to abstinence oriented treatment - is carried out.

Methods: A systematic literature search was performed in 31 international databases which yielded 2451 articles with publication date between 1995 and February 2005.

Results: After a twofold selection process 32 publications were included for assessment and 276 publications were used as background literature. Despite serious restrictions due to selection bias and dropout in most studies focusing on substitution treatment, reduction of consumption of illegal opioids, reduction of risk behaviour, criminal behaviour, mortality and incidence of HIV can be seen as an empirically proven success of substitution treatment. Concerning the improvement of life and health situation the results of the studies are contradictory. The results show that retention rate of substitution treatment is higher than retention rate of abstinence oriented treatment. Regarding economical aspects substitution treatment is efficient in avoiding secondary illnesses (infections) and decreasing criminality. From the perspective of medical ethics substitution treatment as well as medical prescription of heroin is in principle acceptable.

Discussion and conclusions: Based on these results, it can be recommended that substitution treatment in principle should be made available for all opioid dependent persons. The decision whether substitution treatment or another treatment (e. g. abstinence oriented treatment) is more promising has to take into account the individual situation of the client. In addition a combination of substitution treatment and abstinence oriented treatment might be promising although there is a lack of studies about this approach. In any case the decision concerning a certain form of treatment should leave aside pseudo-moralic concerns and should be made on the base of established medical ethic principles - like the interest of the patient - taking into account the specific situation of the client.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country. Q-SEA - a tool for quality assessment of ethics analyses conducted as part of health technology assessments. Effects of continuous and intermittent renal replacement therapies among adult patients with acute kidney injury. Telemedicine: The legal framework (or the lack of it) in Europe. Complex health care interventions: Characteristics relevant for ethical analysis in health technology assessment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1